Canaccord Genuity Maintains a 'Buy' on Synta Pharma. (SNTA); Q3/11 Update
Tweet
Share
E-mailGet Alerts SNTA Hot Sheet
Price: $0.34 --0%
Rating Summary:
4 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
4 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Synta Pharma. (NASDAQ: SNTA) price target of $8.00.
Canaccord analyst, George Farmer, said, "We maintain our BUY rating as we see attractive risk/reward for ganetespib (g-pib) for treatment of non-small cell lung cancer (NSCLC) and potential for expansion into additional oncology indications."
"Q3 cash of $50.7M and our YE estimate of $40M should be good into H2/12, in line with guidance. Partnership discussions for global rights to the CRACM ion channel program and regional rights to ganetepib are expected end of 2011 or early 2012."
For an analyst ratings summary and ratings history on Synta Pharma. click here. For more ratings news on Synta Pharma. click here.
Shares of Synta Pharma. closed at $3.55 yesterday.
Canaccord analyst, George Farmer, said, "We maintain our BUY rating as we see attractive risk/reward for ganetespib (g-pib) for treatment of non-small cell lung cancer (NSCLC) and potential for expansion into additional oncology indications."
"Q3 cash of $50.7M and our YE estimate of $40M should be good into H2/12, in line with guidance. Partnership discussions for global rights to the CRACM ion channel program and regional rights to ganetepib are expected end of 2011 or early 2012."
For an analyst ratings summary and ratings history on Synta Pharma. click here. For more ratings news on Synta Pharma. click here.
Shares of Synta Pharma. closed at $3.55 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
